Biora Therapeutics, Inc. (NASDAQ:BIOR) Q1 2023 Earnings Call Transcript

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q1 2023 Earnings Call Transcript May 15, 2023

Biora Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.59, expectations were $-1.75.

Operator: Welcome to the Biora Therapeutics First Quarter 2023 Financial Results Call. [Operator Instructions]. I will now turn the call over to Kristy Grabowski, Director of IR Communications with LifeSci Advisors Biora’s Investor Relations firm. Thank you. Please go ahead.

Kristy Grabowski: Thank you,...